Cite
HARVARD Citation
Song, X. et al. (n.d.). 203 Population pharmacokinetics of MEDI4736, a fully human antiprogrammed death ligand 1 (PD-L1) monoclonal antibody, in patients with advanced solid tumors. European journal of cancer. pp. S28-. [Online].